UNITED ~~STATESSECURITIES~~STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

Washington, D.C. 20549

FORM 10-Q

[X]	QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	FOR THE QUARTERLY PERIOD ENDED OCTOBER 31, 2014
OR
[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

[X] QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2015

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 333 -191251

~~OVERTECH~~MEDICUS ~~CORP~~HOMECARE INC. (Exact name of registrant as specified in its charter)

(Exact name of registrant as specified in its charter)

Nevada	33-1227048
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

Nevada		7392	None
Waiblingerstrasse 34
(State or Other Jurisdiction of Incorporation or Organization)		(Primary Standard Industrial Classification Number)	(IRS Employer Identification Number)
Stuttgart, Germany	70372
(Address of principal executive offices)	(Zip code)

~~Waiblingerstrasse~~+49 34157 894 69537 (Registrant’s telephone number, including area code)

~~Stuttgart~~n/a (Former name, ~~Germany~~former address and former fiscal year, if changed since last report)

~~49-157-894-69537~~Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days.YES [ X ] NO [ ]

(Address and telephone number of principal executive offices)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES [X] NO [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer, “accelerated filer,” “non-accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [ ] Smaller Reporting Company [ X ]

~~Accelerated~~Indicate ~~filer~~by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES [ ] NO [ X ]

~~Non-accelerated~~State ~~filer~~the [number ]of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 72,960,000 as of February 2, 2016.

Smaller reporting company [X]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

YES [X] NO [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

YES [ ] NO [X]

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 70,560,000 as of November 25, 2014.

TABLE OF CONTENTS

PART I FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION		3
ITEM 1	FINANCIAL STATEMENTS (UNAUDITED)	3
ITEM 1.	FINANCIAL STATEMENTS	3
	BALANCE SHEETS	3
ITEM 2.	MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION	9
	STATEMENTS OF OPERATIONS	4
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.	13
	STATEMENTS OF CASH FLOWS	5
ITEM 4.	CONTROLS AND PROCEDURES	13
	NOTES TO FINANCIAL STATEMENTS	6
PART II. OTHER INFORMATION		14
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	8
ITEM 1.	LEGAL PROCEEDINGS	14
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	10
ITEM 1A.	RISK FACTORS.	14
ITEM 4.	CONTROLS AND PROCEDURES	11
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	14
PART II OTHER INFORMATION
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	14
ITEM 1	LEGAL PROCEEDINGS	11
ITEM 4.	SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS	14
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	11
ITEM 5.	OTHER INFORMATION	14
ITEM 3	DEFAULTS UPON SENIOR SECURITIES	11
ITEM 6.	EXHIBITS	15
ITEM 4	SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS	11
SIGNATURES		17
ITEM 5	OTHER INFORMATION	12
ITEM 6	EXHIBITS	12
	SIGNATURES	12

3PART I - FINANCIAL INFORMATION

~~PART~~Item I1. Financial Statements

~~FINANCIAL~~The ~~INFORMATION~~accompanying unaudited consolidated interim financial statements of Medicus Homecare Inc. as at March 31, 2015, have been prepared by our management in conformity with accounting principles generally accepted in the United States of America and in accordance with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X and, therefore, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, cash flows, and stockholders' equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature.

~~Item~~Operating 1results for the three month period ended March 31, 2015 are not necessarily indicative of the results that can be expected for the year ending December 31, 2015.

~~Financial~~As ~~Statements~~used in this Quarterly Report, the terms “we,” “us,” “our,” “Medicus,” and the “Company” mean Medicus Homecare Inc. and its subsidiary, Beatmungspflege 24 GmbH (“GmbH”), unless otherwise indicated. All dollaramounts in this Quarterly Report are expressed in U.S. dollars, unless otherwise indicated.

4MEDICUS HOMECARE INC. (FORMERLY OVERTECH CORP.) CONSOLIDATED BALANCE SHEETS (EXPRESSED IN US DOLLARS)

OVERTECH CORP.

					December 31,
		March 31, 2015			2014
		(unaudited)
ASSETS

Current assets
Cash	$	2,338		$	299
Accounts receivable		2,161			1,618
Prepaids		10,455			11,404
Due from related parties		750,045			784,727
		764,999			798,048

Property and equipment		132,215			155,323
	$	897,214		$	953,371

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current liabilities
Bank indebtedness	$	81,395		$	188,143
Accounts payable and accrued liabilities		147,004			159,686
Payroll liabilities		135,575			159,558
Other liabilities		56,160			107,693
Due to related parties		219,368			213,095
Income taxes		56,942			6,869
		696,444			835,044

Long-term loan		118,153			133,107
Total liabilities		814,597			968,151

Stockholders' deficit
Common stock $0.001 par value, 75,000,000 common shares authorized, 72,560,000 issued and outstanding at March 31, 2015 and December 31, 2014		72,975			72,975
Additional paid-in capital		1,658,000			1,658,000
Comprehensive loss		(29,022	)		(11,378	)
Accumulated deficit		(1,619,336	)		(1,734,377	)
		82,617			(14,780	)
	$	897,214		$	953,371

~~CONSOLIDATED~~The ~~FINANCIAL~~accompanying ~~STATEMENTS~~notes are an integral part of these unaudited condensed interim consolidated financial statements.

~~October~~(EXPRESSED ~~31,~~IN ~~2014~~US DOLLARS) (unaudited)

(Unaudited)

		Three Months
		Ended March 31,
		2015

Revenue from services	$	1,360,834
Cost of sales		(1,138,505	)
Net revenue		222,329

Operating expenses
Administrative fees		9,000
Audit and accounting fees		15,803
Depreciation		5,926
Facility rent and maintenance costs		637
Foreign exchange		(3,353	)
Legal fees		26,033
Other operating expenses		364
Regulatory fees		3,288
Total operating expenses		57,698

Net income before taxes and interest		164,631
Other income or expenses		(3,677	)
Net income before tax		168,308

Provision for income tax		53,267
Net Income	$	115,041

Other comprehensive loss
Exchange differences on translation		(17,644	)
Net and comprehensive income	$	97,397

Net income per share - basic and diluted	$	0.00


Weighted average number of shares outstanding - basic and diluted		72,560,000

5The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.

~~OVERTECH~~The ~~CORP~~Company has no transactions for the period from January 30, 2014 (inception) to March 31, 2014. Accordingly, no comparative information has been presented.

MEDICUS HOMECARE INC. CONSOLIDATED ~~BALANCE~~STATEMENTS ~~SHEETS~~OF CASH FLOWS (EXPRESSED IN US DOLLARS) (Unaudited)

	October 31, 2014	July 31, 2014
		Three Months Ended
	(Unaudited)
		March 31, 2015
ASSETS
Cash flows generated by operating activities
Current assets
Net income	$	115,041
Prepaids	$ -	$ 14,757
Non cash items
Total assets	$ -	$ 14,757
Amortization		5,926
LIABILITIES AND STOCKHOLDERS' DEFICIT
Changes in operating assets and liabilities
Current liabilities
Accounts receivable		(760	)
Accounts payable and accrued liabilities	$ 62,767	$ 36,098
Related party receivables		(56,033	)
	62,767	36,098
Prepaids		(348	)
Stockholders' deficit
Accounts payable and accrued liabilities		(8,557	)
Common stock $0.001 par value, 75,000,000 common shares authorized, 70,560,000 shares issued and outstanding at October 31, 2014 and July 31, 2014	70,560	70,560
Payroll liabilities		(6,344	)
Additional paid in capital	(39,760)	(39,760)
Other liabilities		(41,312	)
Accumulated deficit	(93,567)	(52,141)
Related party payables		30,979
	(62,767)	(21,341)
Income taxes		53,267
Total liabilities and stockholders deficit	$ -	$ 14,757
Net cash provided by operating activities		91,859
Cash flows used in financing activities
Bank indebtedness		(89,688	)
Net cash used in financing activities		(89,688	)
Effects of foreign currency exchange		(132	)
Net increase in cash		2,039
Cash, beginning		299
Cash, ending	$	2,338
Cash paid for:
Income tax	$	-
Interest	$	-

The accompanying notes are an integral part of these ~~consolidated~~unaudited condensed interim consolidated financial statements.

6The Company has no transactions for the period from January 30, 2014 (inception) to March 31, 2014. Accordingly, no comparative information has been presented.

MEDICUS HOMECARE INC. (FORMERLY OVERTECH CORP.) NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS MARCH 31, 2015 (EXPRESSED IN US DOLLARS)

~~CONSOLIDATED~~NOTE ~~STATEMENTS~~1 OF– ~~OPERATIONS~~ORGANIZATION

Medicus Homecare Inc. (~~Unaudited~~formerly Overtech Corp.) (the “Company”) was incorporated in the state of Nevada on November 13, 2012. On September 2, 2014, the Company established a wholly owned subsidiary, Medicus Homecare Inc. (the “Subsidiary”) under the laws of the state of Nevada.

	Three Months ended October 31,	Three Months ended October 31,
	2014	2013
Advertising and promotion	$ 3,096	$ -
General and administrative expenses	10,006	8,562
Professional fees	25,825	-
Filing fees	2,499	-
Net loss	$ 41,426	$ 8,562
Net loss per share - basic and diluted	$ -	$ -
Weighted average number of shares outstanding - basic and diluted	59,350,027	144,000,000

On November 12, 2014, the Company completed the acquisition of Beatmungspflege 24 GmbH (“GmbH”), which was incorporated on January 30, 2014. GmbH provides in-home nursing care services in Germany. The acquisition of the GmbH was accounted for as a reverse takeover and these unaudited interim consolidated financial statements reflect the transactions and activity of GmbH.

~~The~~Unaudited ~~accompanying~~Interim ~~notes~~Financial ~~are~~Statements ~~an integral part of these consolidated interim financial statements~~

7The unaudited interim consolidated financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). They do not include all information and footnotes required by GAAP for complete financial statements. Except as disclosed herein, there have been no material changes in the information disclosed in the notes to the consolidated financial statements for the year ended December 31, 2014, included in the Company’s Transition Report on Form 10-K, filed with the SEC. The unaudited interim consolidated financial statements should be read in conjunction with those audited consolidated financial statements included in Form 10-K. In the opinion of management, all adjustments considered necessary for fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the three month period ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015.

~~OVERTECH~~Going ~~CORP.~~Concern

~~CONSOLIDATED~~The ~~STATEMENT~~accompanying OFunaudited ~~STOCKHOLDERS'~~interim ~~DEFICIT~~consolidated financial statements have been prepared assuming the Company will continue as a going concern. Continuation as a going concern is dependent upon the ability of the Company to obtain the necessary financing to meet obligations and pay its liabilities arising from normal business operations when they come due and ultimately upon its ability to maintain profitable operations. The outcome of these matters cannot be predicted with any certainty at this time and raise substantial doubt that the Company will be able to continue as a going concern. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern. If necessary, management intends to obtain additional funding by borrowing funds from its directors and officers, issuing promissory notes and/or a private placement of common stock.

~~FOR~~NOTE ~~THE~~2 ~~THREE~~– ~~MONTHS~~COOPERATION ~~ENDED~~AGREEMENT ~~OCTOBER 31, 2014~~

On July 1, 2014, GmbH entered into a cooperation agreement (~~Unaudited~~the “Cooperation Agreement”) with Medicus Intensivpflege GmbH (“MI GmbH”), a company owned by the President, CEO and Director of the Company. MI GmbH has been granted a “Versorgungsvertrag with AOK” license (the “License”) by the German statutory health insurance fund that allows MI GmbH to bill its services to the public health insurance funds rather than to patients or private health insurances. Based on the Cooperation Agreement, MI GmbH agreed to provide medical in-home nursing care services under MI GmbH License exclusively to the Company’s patients in exchange for 15% fee on the gross revenues generated from the services.

	Common shares		Additional
	Number of		Paid-in	Accumulated
	Shares	Amount	Capital	Deficit	Total
Balance at November 13, 2012	-	$ -	$ -	$ -	$ -
Shares issued for cash	144,000,000	144,000	(138,000)	-	6,000
Net loss for the period from inception (November 13, 2012) to July 31, 2013	-	-	-	(173)	(173)
Balance at July 31, 2013	144,000,000	144,000	(138,000)	(173)	5,827
Net loss for the three months ended October 31, 2013	-	-	-	(8,562)	(8,562)
Balance at October 31, 2013	144,000,000	144,000	(138,000)	(8,735)	(2,735)
Shares issued for cash	29,760,000	29,760	(4,960)	-	24,800
Shares returned to treasury	(103,200,000)	(103,200)	103,200	-	-
Net loss for the nine months ended July 31, 2014	-	-	-	(43,406)	(43,406)
Balance at July 31, 2014	70,560,000	70,560	(39,760)	(52,141)	(21,341)
Net loss for the three months ended October 31, 2014	-	-	-	(41,426)	(41,426)
Balance at October 31, 2014	70,560,000	$ 70,560	$ (39,760)	$ (93,567)	$ (62,767)

The Cooperation Agreement may be terminated at any time upon the Company being granted a License. Please refer to the Note 3 for details on the revenue and costs associated with the Cooperation Agreement.

~~All~~NOTE ~~current~~3 ~~and~~– ~~comparative~~RELATED ~~references~~PARTY toTRANSACTIONS ~~the number of shares, weighted average number of common shares and loss per share have been restated to give effect to the common stock dividend of 23 additional shares for each share held (Note 2).~~

~~The~~Amounts ~~accompanying~~due ~~notes~~to/from ~~are~~related anparties ~~integral~~at ~~part~~March of31, ~~these~~2015: ~~consolidated interim financial statements~~

		March 31, 2015		December 31, 2014
Due to the spouse of the President, Chief Executive Officer (“CEO”) and Director	$	189,761	$	210,734
Due to a company owned by the President, CEO and Director		10,689		2,361
Due to the President, CEO and Director		18,918		-
Amounts due to related parties		219,368		213,095

Due from the President, CEO and Director		-		2,926
Due from MI GmbH		739,991		770,557
Due from a company owned by the President, CEO and Director		10,054		11,243
Amounts due from related parties		750,045		784,726
Net amount due from related parties	$	530,677	$	571,631

~~OVERTECH~~During ~~CORP.~~the period ended March 31, 2015, the Company incurred the following transactions with MI GmbH under the Cooperation Agreement (Note 2):

CONSOLIDATED STATEMENTS OF CASH FLOWS

		March 31, 2015
Net proceeds from nursing care services generated	$	1,360,834
Cost of nursing care services incurred		854,109
Fee payable by the Company		204,125

~~(Unaudited)~~NOTE 4 – PROPERTY AND EQUIPMENT

	Three Months ended October 31,	Three Months ended October 31,
							Effect of
	2014	2013
		December 31,					Foreign
Cash flows used in operating activities
		2014		Depreciation			Exchange			March 31, 2015
Net loss	$ (41,426)	$ (8,562)
Land	$	33,155	$	-		$	(3,725	)	$	29,430
Changes in operating assets and liabilities:
Buildings		68,588		(360	)		(7,690	)		60,538
Prepaids	14,757	5,000
Vehicles		51,395		(4,989	)		(5,548	)		40,858
Accounts payable and accrued liabilities	26,669	500
Computer hardware		254		-			(29	)		225
Net cash used in operating activities	-	(3,062)
Furniture and fixtures		1,931		(577	)		(190	)		1,164
Cash flows from financing activities
Total property and equipment	$	155,323	$	(5,926	)	$	(17,182	)	$	132,215
Advances	-	5,000
Net cash provided by financing activities	-	5,000
Net increase in cash	-	1,938
Cash, beginning	-	5,927
Cash, ending	$ -	$ 7,865
Cash paid for:
Interest	$ -	$ -
Income tax	$ -	$ -

The ~~accompanying~~buildings ~~notes~~include two offices which are anused ~~integral~~by ~~part~~the ofCompany to provide outpatient care and other regular business operations. To acquire these ~~consolidated~~premises ~~interim~~the ~~financial~~Company ~~statements~~secured a long-term debt for the total of EUR 110,000 (USD $118,153). The loan bears interest at 4.8% per annum, due in November 2018 and is secured by their principal executive office.

9NOTE 5 - SHARE CAPITAL

~~OVERTECH~~Effective ~~CORP~~August 4, 2014, the Company completed a 23-for-1 stock split. All number of share and per-share disclosures have been retroactively restated to reflect the effect of the share split.

~~NOTES~~NOTE TO6 ~~THE~~- ~~CONSOLIDATED~~SUBSEQUENT ~~INTERIM~~EVENTS ~~FINANCIAL STATEMENTS~~

~~OCTOBER~~On 31April 17, ~~2014~~2015, the Company entered into an agreement to acquire all issued and outstanding shares of Medicus Intensive Care GmbH for the total consideration of EUR 35,000 (USD $37,730).

~~NOTE~~On 1November –25, ~~NATURE~~2015, OFthe ~~OPERATIONS~~Company OFcompleted ~~CONTINUANCE~~a OFprivate ~~BUSINESS~~placement of common shares for an aggregate of 250,000 shares of common stock at EUR 0.32 per share for total proceeds of EUR 80,000.

~~Overtech~~On ~~Corp.~~January (“11, 2016, the Company”) ~~was~~completed ~~incorporated~~a ~~under~~private ~~the~~placement with ~~laws~~its ofCFO ~~the~~and ~~State~~issued ~~of Nevada~~150,000 Uunits at $0.S.20 onper ~~November~~unit ~~13,~~for ~~2012. On~~gross ~~November~~proceeds 12of $30,000. ~~2014,~~Each ~~the~~unit ~~Company~~is ~~entered~~comprised ~~into~~of aone common share ~~purchase~~and ~~agreement~~one towarrant ~~acquire~~that ~~all~~is exercisable ~~the~~for ~~outstanding~~a ~~common~~period ~~shares~~ of ~~Beatmungspflege~~2 24years ~~GmbH~~from ~~(“Beatmungspflege”)~~issuance ~~(Note~~at 3)$0.30.

~~Basis~~On ofJanuary ~~presentation~~12, 2016, the Company entered into a loan agreement for $20,000. The loan is due on demand, unsecured and non-interest bearing.

The unaudited interim consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. They do not include all information and notes required by generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the notes to the financial statements included in the Annual Report on Form 10-K of Overtech Corp. for the year ended July 31, 2014. In the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended October 31, 2014, are not necessarily indicative of the results that may be expected for the year ending July 31, 2015. For further information, these unaudited financial statements and the related notes should be read in conjunction with the Company’s audited financial statements for the year ended July 31, 2014, included in the Company’s report on Form 10-K.

NOTE 2 – COMMON STOCK

On August 4, 2014, the Company completed a 24-for-1 forward stock split by way of a stock dividend. Each shareholder received 23 additional shares for each share held on the record date of August 1, 2014. All current and comparative references to the number of common shares, weighted average number of common shares and loss per share have been restated to give effect to the stock dividend.

NOTE 3 – SUBSEQUENT EVENTS

On November 12, 2014, the Company’s wholly-owned subsidiary, Medicus Homecare Inc. (“Medicus”), Dr. Orhan Karahodza (“Vendor”) and Beatmungspflege executed an agreement and deed of transfer (the “Agreement”), pursuant to which Medicus paid $100 for all of the outstanding common shares of Beatmungspflege. Subsequent to the closing of the Agreement, Medicus will merge with the Company and Beatmungspflege will become a wholly owned subsidiary of Overtech. Upon completion of the merger, the officers and directors of Beatmungspflege will become the officers and directors of Overtech and Overtech will adopt the business plan of Beatmungspflege. Beatmungspflege is the accounting acquirer (legal acquiree) and Overtech is the accounting acquiree (legal acquirer).

The former shareholder and management of Beatmungspflege will own approximately 58% of the total issued and outstanding common shares of Overtech, resulting in a reverse takeover and recapitalization under US Generally Accepted Accounting Principles.

On closing, the Company paid a finders fee of 2,000,000 shares.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

~~Forward~~ FORWARD ~~Looking~~LOOKING ~~Statements~~STATEMENTS

~~Statements~~ The ~~made~~information in this ~~Form~~discussion 10contains forward-Qlooking ~~that~~statements. ~~are~~These ~~not historical or current facts are "~~forward-looking statements" ~~made~~involve ~~pursuant~~risks toand ~~the~~uncertainties, ~~safe~~including ~~harbor~~statements ~~provisions~~regarding ofour ~~Section~~capital ~~27A~~needs, ofbusiness ~~the~~strategy ~~Securities~~and ~~Act~~expectations. ofAny ~~1933~~statements ~~(the~~contained herein ~~"Act")~~that ~~and~~are ~~Section~~not ~~21E~~statements of ~~the~~historical ~~Securities~~facts ~~Exchange~~may ~~Act~~be ofdeemed ~~1934.~~to ~~These~~be forward-looking statements. ~~often~~In ~~can~~some becases, ~~identified~~you bycan ~~the~~identify ~~use~~forward-looking ofstatements ~~terms~~by terminology such as "“may,"” "“will,"” "“should,” “expect,"” ~~"believe~~“plan,"” "“intend,” “anticipate,"” "“believe,” “estimate,"” ~~"approximate"~~“predict,” “potential” or "“continue,"” or the negative ~~thereof.~~of ~~We intend that~~ such ~~forward-looking~~terms ~~statements~~or beother comparable ~~subject~~terminology. toActual ~~the~~events ~~safe~~or ~~harbors~~results ~~for~~may ~~such~~differ ~~statements~~materially. WeIn ~~wish~~evaluating tothese ~~caution readers not to place undue reliance on any such forward-looking~~ statements, ~~which~~you ~~speak~~should ~~only~~consider asvarious offactors, including the ~~date~~risks ~~made.~~described ~~Any~~below, ~~forward-looking~~and, ~~statements~~from ~~represent~~time ~~management's best judgment as~~ to ~~what~~time, ~~may occur~~ in ~~the~~other ~~future.~~reports ~~However,~~we ~~forward-looking~~file ~~statements~~with ~~are~~the ~~subject~~United toStates Securities ~~risks, uncertainties~~ and ~~important~~Exchange ~~factors~~Commission ~~beyond~~(the ~~our~~“SEC”). ~~control~~These ~~that~~factors ~~could~~may cause our actual results ~~and events~~ to differ materially from ~~historical~~any ~~results~~forward-looking ~~of operations and events and those presently anticipated or projected~~statement. We disclaim any obligation ~~subsequently~~ to ~~revise~~publicly ~~any~~update ~~forward-looking~~these statements, ~~to reflect events~~ or ~~circumstances~~disclose ~~after~~any difference ~~the~~between ~~date~~its ofactual ~~such~~results ~~statement~~and orthose toreflected ~~reflect~~in ~~the~~these ~~occurrence of anticipated or unanticipated events~~statements.

~~Introduction~~ We cannot predict all of the risks and uncertainties. Accordingly, such information should not be regarded as representations that the results or conditions described in such statements or that our objectives and plans will be achieved and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements. These forward-looking statements are found at various places throughout this Report and include information concerning possible or assumed future results of our operations, including statements about potential acquisition or merger targets; business strategies; future cash flows; financing plans; plans and objectives of management, any other statements regarding future acquisitions, future cash needs, future operations, business plans and future financial results, and any other statements that are not historical facts.

We These ~~were~~forward-looking ~~incorporated~~statements ~~on November~~represent 13our intentions, ~~2012~~plans, inexpectations, ~~the~~assumptions ~~State~~and ofbeliefs ~~Nevada. We~~about ~~are~~future inevents ~~the~~and ~~business~~are ofsubject ~~providing~~to ~~medical~~risks, ~~in-home~~uncertainties ~~care~~and ~~services~~other ~~including~~factors. ~~ventilation~~Many ~~for~~of ~~patients~~those ~~that~~factors ~~suffer~~are ~~from~~outside ~~debilitating~~of ~~diseases~~our ~~such~~control asand ~~amyotrophic~~could ~~Lateral~~cause actual ~~Sclerosis~~results ~~(ALS),~~to ~~Muscular~~differ ~~Dystrophy~~materially ~~(MD),~~from ~~Guillain-Barre~~the ~~Syndrome~~results ~~(GBS)~~expressed ~~and~~or ~~Chronic~~implied ~~Obstructive~~by ~~Pulmonary~~those ~~Disease~~forward-looking ~~(COPD)~~statements. ~~Other~~ ~~services~~In ~~include~~light ~~Acute~~of ~~post-patient~~these ~~car~~risks, ~~respiration~~uncertainties ~~optimization~~ and ~~monitoring~~assumptions, ofthe ~~long~~events ~~term~~described ~~home~~in ~~respiration~~the ~~with~~forward-looking ~~nationwide~~statements ~~care~~might ~~available~~not ~~within~~occur 24or ~~hours~~might occur ~~for~~to ~~all~~a ~~respiration~~different ~~cases.~~extent ~~Our~~or ~~operations~~at toa ~~date~~different time than we have ~~been~~described. ~~devoted~~You ~~primarily~~are cautioned not to ~~start-up~~place ~~and~~undue ~~development~~reliance ~~activities~~on these forward-looking statements, which ~~include:~~speak ~~(i)~~only ~~formation~~as of the ~~Company;~~date ~~(ii)~~of ~~development~~this ofReport. ~~our~~All ~~business~~subsequent ~~plan;~~written ~~(iii)~~and ~~website~~oral forward-looking ~~development,~~statements concerning other matters addressed in this Report and ~~(iv)~~attributable ~~purchase~~to ofus or any person acting on our behalf are expressly qualified in their entirety by the ~~medical~~cautionary ~~business~~statements contained or referred to in this Report.

~~Acquisition~~ Except ~~Agreement~~to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

On As ~~September~~used 3,in ~~2014~~this Quarterly Report, wethe ~~entered~~terms ~~into~~“we,” a“us,” ~~Share~~“our,” ~~Purchase~~“Overtech,” ~~Agreement~~and (the ~~"Share~~“Company” ~~Purchase~~mean ~~Agreement") with our wholly-owned subsidiary,~~ Medicus Homecare Inc. (~~the~~formerly “~~Subsidiary~~Overtech Corp.”), ~~Dr.~~and ~~Orhan~~our ~~Karahodza (the “Vendor”)~~subsidiary, Beatmungspflege 24 GmbH (~~the "~~“GmbH"”), ~~and~~unless ~~Dr.~~otherwise ~~Elmedina Adzemovic for the acquisition of the GmbH from the Vendor by the Subsidiary~~indicated. ~~The~~All ~~GmbH~~dollar ~~was~~amounts ~~formed to acquire the medical~~ in~~-home~~ ~~care~~this ~~services~~Quarterly ~~proprietorships~~Report ~~operated~~are byexpressed ~~Dr.~~in ~~Orhan Karahodza and Dzenana Karahodza for several years under the names Das Pflegeland and Premium-Pflegedienst Pflegeland (the “Predecessors”)~~U. ~~The GmbH acquired the Predecessors under contribution agreements dated effective as at July 1, 2014 (the “Contribution Agreements”)~~S. ~~Prior~~ ~~to the acquisition of the Predecessors~~dollars, ~~the~~unless ~~GmbH~~otherwise ~~did not carry on any business~~indicated.

~~Under~~ OVERVIEW the terms of the Share Purchase Agreement, the Subsidiary, acquired the GmbH for a consideration of USD$100. Concurrent with Closing of the acquisition, our former President, Dr. Elmedina Adzemovic, transferred 40,800,000 of shares of our common stock held by her to the Vendor. As a result of the transfer of her shares to the Vendor, Dr. Adzemovic no longer owns any shares of our common stock Accordingly, there was a change in control and Dr. Orhan Karahodza now controls 57.8% of the issued and outstanding shares of our common stock.

On We were incorporated on November 1213, ~~2014~~2012, ~~upon~~under ~~closing of~~ the ~~acquisition~~laws of the ~~GmbH,~~State Drof Nevada. ~~Elmedina~~Our ~~Adzemovic~~principal ~~resigned~~offices asare ~~our~~located ~~Chief~~at ~~Executive~~Waiblingerstrasse ~~Officer~~34, ~~President~~Stuttgart, ~~Secretary and Treasurer~~Germany. ~~The~~Our ~~resignations~~telephone ofnumber ~~Dr.~~is ~~Adzemovic~~+49 ~~were~~157 ~~made~~894 ~~in accordance with the terms of the Share Purchase Agreement and were not due to any us~~69537. ~~She continues to act as our Chief Financial Officer and as a Director.~~

~~Upon~~ On November 12, 2014, we completed the ~~tendering~~acquisition of ~~Dr.~~GmbH, ~~Adzemovic’s~~which ~~resignations~~was incorporated on January 30, Dr2014. ~~Orhan~~As ~~Karahodza~~a ~~was~~result ~~appointed~~of tothe acquisition, we have changed our ~~Board~~business ofto ~~Directors~~providing ~~and~~medical in-home care services in Germany including ventilation for patients that suffer from debilitating diseases such as ~~our~~Amyotrophic ~~Chief~~Lateral ~~Executive~~Sclerosis ~~Officer~~(ALS), ~~President~~Muscular Dystrophy (MD), ~~Secretary~~Guillain-Barre syndrome (GBS), and ~~Treasurer~~Chronic Obstructive Pulmonary Disease (COPD). Other services provided by GmbH include acute post-patient care, respiration optimization and monitoring of long-term home respiration.

On Over ~~November 12, 2014, as a result of~~ the ~~acquisition~~next oftwo ~~the~~years ~~GmbH,~~we ~~our~~plan ~~fiscal~~to ~~year~~open ~~end~~additional ~~has~~local ~~changed~~checkpoints ~~from~~which ~~July 31 to December 31. Accordingly, we~~ will beaffect ~~filing~~ our ~~next~~assets, ~~Annual~~liabilities, ~~Report~~liquidity onand ~~Form~~working ~~10-K~~capital. ~~for the year ended December 31, 2014~~

AsOur revenue is recognized on a ~~result~~monthly ofbasis by invoicing the services ~~acquisition~~provided ofin ~~the~~that month. Services are invoiced by Medicus Intensivpflege GmbH (“MI GmbH”), wepursuant ~~changed~~to our ~~business~~cooperation toagreement ~~providing~~dated ~~medical~~July ~~in-home~~1, 2014, ~~care~~to ~~services~~the inpublic ~~Germany.~~health Ininsurance ~~addition~~funds, ~~the~~private ~~acquisition~~health ofinsurance or the customer ~~GmbH~~directly. ~~has~~Our ~~the~~services ~~effect~~are ofprovided ~~causing~~on usan tohourly ~~cease~~basis ~~being~~and the services billed are at a ~~“shell~~determined ~~company~~price by health insurance companies.”

11Approximately 85% of our services are billed and paid by the public health insurance, 10% by private health insurance and 5% paid directly by the customers. The customers are billed if the insurance provider does not cover the service or only covers a percentage of the service.

~~Medical~~Approximately ~~In-Home~~10% ~~Care~~of ~~Services~~the amounts invoiced monthly are written off. This may be due to:

~~The~~• ~~business~~customers ofnot ~~the~~having ~~GmbH~~funds isavailable ~~primarily~~to ~~the~~pay; ~~offering~~• ofthe ~~medical~~insurance ~~in-home~~companies ~~care~~disputing ~~services~~some inof ~~Germany~~the ~~including~~services ~~ventilation~~rendered ~~for patients that suffer from debilitating diseases such as Amyotrophic Lateral Sclerosis~~ (~~ALS), Muscular~~which ~~Dystrophy~~is ~~(MD~~rare),; ~~Guillain-Barre~~or ~~syndrome~~• ~~(GBS),~~if ~~and~~the ~~Chronic~~private ~~Obstructive~~health ~~Pulmonary~~insurance ~~Disease~~only ~~(COPD).~~covers ~~Other~~a ~~services~~portion ~~include~~of ~~acute~~the ~~post-patient~~service ~~care, respiration optimization~~ and ~~monitoring~~the ofcustomer ~~long-term~~does ~~home~~not ~~respiration.~~have the

~~The~~available ~~GmbH~~funds currently operates in the Stuttgart area with two facilities, one of which serves as an office and the other is an acute post care facility with 3 beds outfitted with respiration equipment. The GmbH also has 7 local checkpoints in the Stuttgart area and plans to ~~open~~cover ~~additional checkpoints throughout Germany. The checkpoints are locations where nurses pick up medication, supplies and equipment prior to visiting~~ the ~~patients in their homes~~balance.

AtGenerally, all payments are received within 28 days of invoicing as the ~~present~~insurance ~~time,~~funds have the ~~GmbH~~duty ~~has~~to ~~103~~pay ~~employees~~within ~~and~~28 ~~contractors~~days of ~~which~~being invoiced. 80The ~~are~~only ~~nurses~~time ~~responsible~~the ~~for~~insurance ~~maintenance~~payments ~~and~~will ~~care~~take oflonger ~~patients~~is if there is a dispute regarding the services provided (which is uncommon).

~~Ambulatory~~GmbH ~~care~~currently ~~services~~operates in Stuttgart area with two facilities, one of which serves as an office and ~~nursing~~the ~~care~~other is ~~estimated~~an toacute bepost acare 27facility with ~~billion~~3 ~~EUR~~beds ~~annual~~outfitted ~~market~~with inrespiration ~~Germany~~equipment. ~~The~~GmbH ~~German~~also ~~market~~has ~~for~~7 ~~ambulatory~~local checkpoints ~~care~~in ~~services~~the isStuttgart ~~estimated~~area toand ~~increase~~plans to 50open ~~billion~~additional ~~EUR~~checkpoints throughout byGermany. ~~2020~~The ~~(source:~~checkpoints ~~German~~are ~~Federal~~locations ~~Statistical~~where ~~Office)~~nurses pick up medication, supplies and equipment prior to visiting the patients in their homes.

~~SUMMARY~~At OFpresent ~~FINANCIAL~~time, ~~CONDITION~~MI GmbH has 103 employees and contractors of which 80 are nurses responsible for maintenance and care of patients (which includes 60 full-time nurses and 20 part-time nurses).

~~Table~~Ambulatory 1:care ~~Comparison~~services ofand ~~financial~~nursing ~~condition~~care is estimated to be a 27 billion EUR annual market in Germany.

	October 31, 2014	July 31, 2014	July 31, 2013
Working capital	$(62,767)	$(21,341)	$10,927
Current assets	$0	$14,757	$10,927
Total liabilities	$62,767	$46,198	$5,100
Common stock and additional paid in capital	$30,800	$30,800	$6,000
Deficit	$(93,567)	$(52,141)	$(173)

Corporate Developments

~~RESULTS~~The OFfollowing ~~OPERATION~~corporate developments occurred during the quarter ended March 31, 2015, and up to the date of the filing of this report:

WeAcquisition have not generated any revenue to date and we have incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of ~~assets~~MI ~~and~~GmbH classification of liabilities that might be necessary should we be unable to continue in operation. We expect we will require additional capital to meet our long term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

~~Three~~On ~~months~~April ~~ended~~17, ~~October~~2015, 31we entered into an agreement to acquire all issued and outstanding shares of MI GmbH. Pursuant to the agreement, ~~2014~~we acquired all issued and ~~2013~~outstanding shares of MI GmbH for the total consideration of $37,730 (EUR 35,000). Pursuant to the April 17, 2015 agreement, certain funds of our company were held in trust by related party to effect the purchase of equipment on behalf of the GmbH (the “Funds”). The equipment included, but was not limited to, respirators and medical accessories required for the operations and business of the GmbH. On June 30, 2015, the related party closed the purchase and transferred certain medical equipment to the GmbH (the “Equipment”). However, as a result of the purchase of the Equipment not having been completed and the application of certain accounting rules, the Funds held in trust were classified as a “related party” loan.

~~Our~~Change ~~net~~in ~~loss~~Management ~~for the three months ended October 31, 2014 was $41,426 (2013, $8,562). During the three months ended October 31, 2014 and 2013 we did not generate any revenue.~~

~~During~~Effective ~~the~~January ~~three months ended October 31~~5, ~~2014~~2016, weDr. ~~incurred~~Elmedina ~~general~~Adzemovic ~~and~~resigned ~~administrative~~as our ~~expenses~~Chief ofFinancial ~~$10,006~~Officer ~~(2013, $8,562). General~~ and ~~administrative~~Leon ~~expenses~~Nowek ~~incurred~~delivered ~~during~~his ~~the~~consent ~~three months ended October 31, 2014 were generally related~~ to ~~corporate~~act ~~overhead, financial and administrative contracted services, such~~ as ~~developmental~~our Chief ~~costs,~~Financial ~~and~~Officer. ~~marketing expenses~~Dr. ~~Professional~~Adzemovic’s ~~fees~~resignation ~~incurred~~was innot the ~~three~~result ~~months~~of ~~ended~~any disagreements ~~October~~with ~~31,~~us ~~2014~~regarding ~~were~~our ~~$25~~operations,~~825~~ ~~(2013~~policies, ~~$0). Professional~~practices ~~fees were primarily related to the acquisition of our new subsidiary Beatmungspflege 24 GmbH~~or otherwise.

Mr. Leon Nowek has held numerous management positions with various resource and technology start-up companies including Henfrey & Co. and Nexus Resource group. From 1994 to 2002, Mr. Nowek was co-founder, officer and director of Turbodyne Technologies Inc. He was responsible for financing and completing the company’s listing on the NASDAQ exchange and all of its regulatory filings in the USA, Canada and Europe. From 2002 to 2014, Mr. Nowek was involved in numerous start-up technology companies in USA, Germany and China, as an investor, consultant (on finance, mergers, regulatory filings) and strategic advisor to these young companies. Mr. Nowek is also President, CFO and Director of a small holding and consulting company, Krystal Holdings Inc., since its incorporation in 2006 in Nassau, Bahamas. He is also President, Director, CFO and an investor of a private start-up oil and gas exploration company called Sunspot Energy Corp., a Canadian registered company since April, 2013.

On January 8, 2016, GmbH entered into a consulting agreement with Leon Nowek. Pursuant to this agreement, Mr. Nowek shall assist us with the respect to the financial record keeping and regulatory filings for a term of one year. In exchange for the services, we agreed to compensate Mr. Nowek 4,000 EUR per month, grant him an option to acquire up to 1,000,000 common shares of our company at an exercise price of $0.20 for a period of two years expiring on January 8, 2018.

Private Placements

On November 25, 2015, we completed a private placement of common shares for an aggregate of 250,000 shares of common stock at 0.32 EUR per share for total proceeds of 80,000 EUR to be used as general working capital.

On January 11, 2016, we completed a private placement with Mr. Nowek and issued to Mr. Nowek 150,000 units of our common stock at $0.20 per unit for gross proceeds of $30,000. Each Unit comprises of one common share of our common stock and one whole warrant that is exercisable for a period of 24 months from issuance at an exercise price of $0.30.

Debt Financing

On January 12, 2016, we entered into a loan agreement with an unrelated third party for the total proceeds of $20,000. The loan is due on demand and carries no interest.

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2015 AND 2014

Our operating results for the three month period ended March 31, 2015 are summarized in the table below.

		Three Months Ended
		March 31,
		2015
Revenue from services	$	1,360,834
Cost of sales and other services		(1,138,505	)
Net revenue		222,329

Operating expenses
Administrative fees		9,000
Audit and accounting fees		15,803
Depreciation		5,926
Facility rent and maintenance costs		637
Foreign Exchange		(3,353	)
Legal fees		26,033
Other operating expenses		364
Regulatory fees		3,288
Total operating expenses		57,698
Net income before taxes and interest		164,631
Other income or expenses		3,677
Provision for income taxes		(53,267	)
Net income	$	115,041

Revenues

Our revenue during the three month period ended March 31, 2015 was $1,360,834 and was generated from the medical in-home care services we provide in Germany. The cost of providing the services amounted to $1,138,505 and resulted in overall net revenue from services of $222,329.

GmbH was incorporated on January 30, 2014 and did not have any operations during the first two fiscal quarters, as such we have no comparable transactions during the three month period ended March 31, 2014.

Operating Expenses

We recorded $57,698 in operating expenses during the three months ended March 31, 2015. These expenses were primarily attributable to audit and accounting fees, legal and administrative fees and other operating expenses.

GmbH was incorporated on January 30, 2014 and did not have any operations during the first two fiscal quarters, as such we did not incur any operating expenses during the comparable period.

Net Income

Our net income during the three month period ended March 31, 2015 was $115,041. We did not record any income or loss during the three month period ended March 31, 2014, as GmbH did not have any operations during the comparable period.

LIQUIDITY AND CAPITAL RESOURCES

Three months ended October 31, 2014

*Working Capital*
		As at		As at
		March 31,		December 31,		Percentage
		2015		2014		Change
Current assets	$	764,999	$	798,048		(4.1%	)
Current liabilities		696,444		835,044		(16.6%	)
Working capital (deficit)	$	68,555	$	(36,996	)	(285.3%	)

As of ~~October~~March 31, ~~2014~~2015, ~~our~~we ~~current~~had ~~assets~~a ~~were~~cash $0balance ~~(July~~of ~~31, 2014~~ $142,~~757). As of October 31~~338, ~~2014,~~a working ~~our~~capital ~~current~~of ~~liabilities were~~ $6268,~~767~~555 ~~(July~~and ~~31,~~cash ~~2014~~flows ~~$36,098).~~generated ~~Current~~from ~~liabilities~~our ~~were~~operations ~~comprised~~ of $3291,~~069~~859 infor ~~accounts~~the ~~payable~~three ~~and~~month ~~$30,698~~period inthen ~~advances from an unrelated person~~ended.

Stockholders’ deficit was $93,567 as of October 31, 2014 ($52,141 as of July 31, 2013).

*Cash Flows*
		Three Months Ended
		March 31,
		2015
Cash flows generated by operating activities	$	91,859
Cash flows used in financing activities		(89,688	)
Effects of foreign currency exchange on cash		(132	)
Net increase in cash during the period	$	2,039

12Cash Flows Generated by Operating Activities

~~Cash~~During ~~Flows~~the three month period ended March 31, 2015, we have generated $91,859 from ~~Operating~~our ~~Activities~~operating activities. This cash was generated from net cash income of $115,041 we realized during the period as well as $30,979 increase in due to related parties and $53,267 increase in income taxes payable. These changes were offset in part by increases in our accounts receivable and prepaid expenses of $760 and $348, respectively, and by $56,033 increase in receivables from MI GmbH, pursuant to our cooperation agreement dated July 1, 2014. In addition, we used total of $56,213 to reduce our current and payroll liabilities.

WeGmbH ~~have~~did not ~~generated~~have ~~positive~~any ~~cash~~operations ~~flows~~during ~~from operating activities. For~~ the ~~three~~first ~~months~~two ~~ended October 31~~fiscal quarters, ~~2014,~~as ~~net~~such ~~cash~~we ~~flows~~did ~~used~~not ingenerate ~~operating~~any ~~activities was $0 consisting of a net loss of $41,426, a decrease in prepaid expenses of $14,757 and an increase in accounts payable and $26,669. Net~~ cash ~~flows~~during ~~used in operating activities was $3,062 for~~ the ~~three~~comparative ~~months~~period ~~ended October 31, 2013. This consisted of a net loss of $8,562, a decrease~~ in fiscal ~~prepaids of $5,000 and an increase in accounts payable and accrued liabilities of $500~~2014.

Cash Flows ~~from~~used in Financing Activities

WeDuring ~~have financed our operations primarily from either advances from shareholders or~~ the ~~issuance of equity instruments. For the~~ three ~~months~~month period ended ~~October~~March 31, ~~2014~~2015, ~~cash~~we ~~flow~~used $89,688 ~~provided~~to byreduce ~~financing~~our ~~activities~~bank ~~was a $0~~indebtedness. ~~For~~ ~~the~~We ~~three~~did ~~months~~not ~~ended~~have ~~October~~any ~~31, 2013, net cash provided by~~ financing activities ~~was~~during ~~$5,000~~the ~~from~~comparative ~~advances~~period ~~from~~in afiscal ~~former shareholder~~2014.

PLAN OF OPERATION AND FUNDING

We expect that working capital requirements will be funded through the ongoing operations of our new subsidiary Beatmungspflege 24 GmbH and from further issuances of securities and issuance of debt instruments. Our working capital requirements are expected to increase in line with the growth of our business.

Anticipated cash flow from operations, further issuance of securities and further advances and debt instruments are expected to be adequate to fund our operations over the next year. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations to date through the proceeds of the private placement of equity and debt instruments. In connection with our business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) acquisition of inventory; (ii) expenses associated with expansion of our medical business; and (iii) marketing expenses. We intend to finance these expenses through operating cash flow, further issuances of securities, and debt issuances. To expand our business, we expect we will need to raise additional capital through the securities market. Issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations.

Material Commitments

As of October 31, 2014, we had no material commitments.

Off-Balance Sheet Arrangements

AsWe ~~of the date of this Interim Report, we do not~~ have ~~any~~no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that ~~are~~ is material to ~~investors~~stockholders.

~~Going~~Critical ~~Concern~~Accounting Policies

~~The~~An ~~independent~~appreciation ~~auditors'~~of ~~audit~~our ~~report~~critical ~~accompanying~~accounting ~~our~~policies ~~July~~is necessary ~~31,~~to ~~2014~~understand our financial ~~statements~~results. ~~contains~~These anpolicies ~~explanatory~~may ~~paragraph~~require management ~~expressing~~to ~~substantial~~make ~~doubt~~difficult ~~about~~and ~~our~~subjective ~~ability~~judgments toregarding ~~continue~~uncertainties, and as a ~~going~~result, ~~concern.~~such ~~These~~estimates ~~financial~~may ~~statements~~significantly ~~have~~impact ~~been~~our ~~prepared~~financial ~~"assuming~~results. The ~~that~~precision weof ~~will~~these ~~continue~~estimates asand athe ~~going~~likelihood ~~concern,"~~of ~~which~~future ~~contemplates~~changes ~~that~~depend weon a ~~will~~number ~~realize~~of ~~our~~underlying ~~assets~~variables and ~~satisfy~~a ~~our~~range ~~liabilities~~of ~~and~~possible ~~commitments~~outcomes. inWe ~~the~~have applied ~~ordinary~~our ~~course~~critical ofaccounting ~~business~~policies and estimation methods consistently.

~~ITEM~~Recent 3.Accounting ~~QUANTITATIVE~~Pronouncements ~~AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.~~

~~Not~~Recent accounting pronouncements issued by the Financial Accounting Standards Board or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the financial statements of our Company.

13Changes in and Disagreements with Accountants on Accounting Procedures and Financial Disclosure

None.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

None

ITEM 4. CONTROLS AND PROCEDURES

~~Under~~Our ~~the supervision and with the participation of our~~ management, ~~including~~is ~~our~~responsible ~~Chief~~for ~~Executive~~establishing ~~Officer~~ and ~~Chief~~maintaining a ~~Financial~~system ~~Officer, we have evaluated the effectiveness~~ of ~~our~~ disclosure controls and procedures (as ~~required~~defined byin ~~Exchange~~Rule ~~Act Rules~~ 13a-15(e) and ~~15(d)~~ 15d-15(e) asunder ofthe ~~October~~Securities 31Exchange Act of 1934, ~~2014~~as amended (the “~~Evaluation~~Exchange ~~Date~~Act”).) ~~Based~~that ~~upon~~is designed to ensure that ~~evaluation~~information ~~our~~required ~~Chief~~to be ~~Executive~~disclosed ~~Officer~~by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and ~~Chief~~reported, ~~Financial~~within ~~Officer~~the ~~concluded~~time ~~that~~periods specified ~~our~~in ~~disclosure~~the Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures ~~were~~designed ~~not~~to ensure ~~effective~~that asinformation ofrequired to be disclosed by an issuer in the ~~Evaluation~~reports that ~~Date~~it asfiles aor ~~result~~submits ofunder the ~~material~~Exchange ~~weaknesses~~Act inis ~~internal~~accumulated ~~control~~and ~~over~~communicated to ~~financial~~the ~~reporting~~issuer's ~~discussed~~management, inincluding ~~our~~its ~~Annual~~principal ~~Report~~executive onofficer ~~Form~~or officers ~~10-K~~and ~~for~~principal ~~the~~financial ~~year~~officer ~~ended~~or ~~July~~officers, 31or persons performing similar functions, ~~2014~~as ~~(the~~appropriate ~~“2014~~to ~~Annual~~allow ~~Report”)~~timely decisions regarding required disclosure.

~~Notwithstanding~~An evaluation was conducted under the ~~assessment~~supervision ~~that~~and ~~our~~with ~~internal~~the participation ~~controls~~of ~~over~~our ~~financial~~management ~~reporting~~of ~~were~~the ~~not~~effectiveness ~~effective~~of ~~and~~the ~~that~~design ~~there~~and ~~were~~operation of ~~material~~our ~~weaknesses~~disclosure ascontrols ~~identified~~and inprocedures ~~our~~as ~~2014~~of ~~Annual~~March ~~Report~~31, we2015. ~~believe~~Based on that evaluation, our ~~financial~~management ~~statements~~concluded ~~contained~~that in our ~~Quarterly~~disclosure ~~Report~~controls onand ~~Form~~procedures were ~~10-Q~~effective ~~for~~in ~~the~~recording, ~~fiscal~~processing, ~~quarter~~summarizing ~~ended~~and ~~October~~reporting ~~31,~~information required ~~2014~~to ~~report~~be ~~fairly~~disclosed ~~present~~within ~~our~~the ~~financial~~time ~~condition,~~periods ~~results~~specified ofin ~~operations~~Securities and Exchange ~~cash~~Commission’s ~~flows~~rules inand ~~all material respects~~forms.

~~Changes~~During the quarter ended March 31, 2015, there were no changes in ~~Internal~~our ~~Controls~~internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

There were no changes in our internal control over financial reporting during the fiscal quarter ended October 31, 2014 that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

WeManagement ~~are~~is not aaware ~~party~~of toany legal proceedings contemplated by any governmental authority or any other ~~legal~~party ~~proceedings~~involving ~~and,~~us toor our ~~knowledge~~properties. As of the date of this Quarterly Report, no ~~other~~director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. ~~are~~Management is not aware of any other legal proceedings pending, or that have been threatened against us or ~~contemplated~~our properties.

ITEM 1A. RISK FACTORS

As a smaller reporting company we are not required to provide the information required by this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

~~None~~On November 25, 2015, we completed a private placement of common shares for an aggregate of 250,000 shares of common stock at 0.32 EUR per share for total proceeds of 80,000 EUR to be used as general working capital.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

~~Not Applicable~~None.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

~~Not Applicable~~None.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibit Number	Description of Exhibit
3.1	Articles of Incorporation of Registrant. (1)
3.2	Bylaws of the Registrant. (2)
10.1	Mobile Application Development and Intellectual Property Assignment Agreement, dated August 22, 2013, by and between Overtech Corp and Murad Guseinov. (1)
10.2	Share Purchase Agreement dated September 3, 2014, among Overtech Corp., its wholly-owned subsidiary, Medicus Homecare Inc., Dr. Orhan Karahodza, Beatmungspflege 24 GmbH and Dr. Elmedina Adzemovic(2)
10.3	Contribution Agreement (Das Pflegeland) effective July 1, 2014 between Beatmungspflege 24 GmbH and Dr. Orhan Karahodza (and Dzenana Karahodza as communal property ownership in accordance with Bosnian law).(5)
10.4	Contribution Agreement (Premium-Pflegedienst Pflegeland) effective July 1, 2014 between Beatmungspflege 24 GmbH and Mrs. Dzenana Karahodza (and Dr. Orhan Karahodza as communal property ownership in accordance with Bosnian law).(5)
10.5	Agreement and Deed of Transfer.(5)
14.1	Code of Ethics.(4)
31.1	Certification of Chief Executive Officer as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Chief Financial Officer as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document.
101.SCH	XBRL Taxonomy Extension Schema.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase.
101.DEF	XBRL Taxonomy Extension Definition Linkbase.
101.LAB	XBRL Taxonomy Extension Label Linkbase.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase.

Exhibits:

Notes:

Exhibit	Description of Exhibit

(3)	Articles of Incorporation; Bylaws
3.1	Articles of Incorporation of Registrant.
3.2	Bylaws of the Registrant.
3.3	Certificate of Merger (incorporated by reference to our company’s current report on Form 8-K as filed with the SEC on December 12, 2014 as exhibit 3.1).
3.4	Articles of Merger between Medicus Homecare Inc. (as surviving company) and Medicus Homecare Inc. (as merging entity), with surviving entity changing its name to “Medicus Homecare Inc.” effective December 12, 2014 (incorporated by reference to our company’s current report on Form 8-K as filed with the SEC on December 12, 2014 as exhibit 3.2).
(10)	Material Contracts
10.1	Mobile Application Development and Intellectual Property Assignment Agreement, dated August 22, 2013, by and between Medicus Homecare Inc. and Murad Guseinov (incorporated by reference to our Registration Statement on Form S-1 filed with the SEC on September 19, 2013).
10.2	Share Purchase Agreement dated September 3, 2014, among Medicus Homecare Inc., its wholly-owned subsidiary, Medicus Homecare Inc., Dr. Orhan Karahodza, Beatmungspflege 24 GmbH and Dr. Elmedina Adzemovic (incorporated by reference to our Current Report on Form 8-K filed with the SEC on September 8, 2014).
10.3	Contribution Agreement (Das Pflegeland) effective July 1, 2014 between Beatmungspflege 24 GmbH and Dr. Orhan Karahodza (and Dzenana Karahodza as communal property ownership in accordance with Bosnian law) (incorporated by reference to our Current Report on Form 8-K filed with the SEC on November 19, 2014).
10.4	Contribution Agreement (Premium-Pflegedienst Pflegeland) effective July 1, 2014 between Beatmungspflege 24 GmbH and Mrs. Dzenana Karahodza (and Dr. Orhan Karahodza as communal property ownership in accordance with Bosnian law) (incorporated by reference to our Current Report on Form 8-K filed with the SEC on November 19, 2014).
10.5	Cooperation Agreement between our company and Medicus Intensivpflege GmbH effective July 1, 2014.
10.6	Agreement and Deed of Transfer (incorporated by reference to our Current Report on Form 8-K filed with the SEC on November 19, 2014).
10.7	Form of Subscription Agreement between our company and Leon Nowek (incorporated by reference to our Current Report on Form 8-K filed with the SEC on January 14, 2016).
10.8	Form of Loan Agreement between our company and Aladdin Saracevic (incorporated by reference to our Current Report on Form 8-K filed with the SEC on January 14, 2016).
(14)	Code of Ethics
14.1	Code of Ethics (incorporated by reference to our Annual Report on Form 10-K filed with the SEC on October 29, 2014).
(16)	Letter re Change in Certifying Accountant
16.1	Letter of Dale Matheson Carr-Hilton Labonte, L.L.P. Chartered Accountants (former principal independent accountants) (incorporated by reference to our company’s current report on Form 8-K as filed with the SEC on February 17, 2015 as exhibit 16.1).
16.2	Letter of RBS RoeverBroennerSusat GmbH & Co.KG. (former principal independent accountants) (incorporated by reference to our company’s current report on Form 8-K as filed with the SEC on February 17, 2015 as exhibit 16.2).
(31)	Rule 13a-14(a) / 15d-14(a) Certifications

(1)

31.1	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer.
31.2	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of the Principal Financial Officer and Principal Accounting Officer.

(32)	Section 1350 Certifications
32.1	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer.
32.1	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of the Principal Financial Officer and Principal Accounting Officer.
(101)	Interactive Data File (Form 10-Q for the three months ended March 31, 2015 furnished in XBRL).
101.INS	XBRL Instance Document.
101.SCH	XBRL Taxonomy Extension Schema.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase.
101.DEF	XBRL Taxonomy Extension Definition Linkbase.
101.LAB	XBRL Taxonomy Extension Label Linkbase.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase.

Incorporated by reference to the Company’s Registration Statement on Form S-1 (File No. 333-191251), filed with the SEC on September 19, 2013.

(2)

Incorporated by reference to the Company’s Amendment No. 1 to Registration Statement on Form S-1 (File No. 333-191251), filed with the SEC on November 21, 2013.

(3)

Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on September 8, 2014.

(4)

Incorporated by reference to the Company’s Annual Report on Form 10-K filed with the SEC on October 29, 2014.

(5)

Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on November 19, 2014.

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	OVERTECH CORP.
	MEDICUS HOMECARE INC.
Dated: December 11, 2014	By: /s/ Orhan Karahodza
Dated: February 4, 2016	By: /s/Orhan Karahodza
	Orhan Karahodza President, Secretary, Treasurer, Chief Executive Officer (Principal Executive Officer)
	Dr. Orhan Karahdza
	President, Secretary, Treasurer, Chief Executive
	Officer and Director
	(Principal Executive Officer)
	By: /s/Leon Nowek
	Leon Nowek
	Chief Financial Officer
	(Principal Accounting Officer)

Filing Compare · MEDICUS HOMECARE INC.